Lars Heslet

Randomized evaluation of pulse oximetry in 20,802 patients. II: Perioperative events and postoperative complications

BackgroundThe authors describe the effect of pulse oximetry monitoring on the frequency of unanticipated perl-operative events, changes In patient care, and the rate of postoperative complications in a prospective randomized study. MethodsThe study Included 20,802 surgical patients in Denmark randomly assigned to be monitored or not with pulse oximetry In the operating room (OR) and postanesthesla care unit (PACU). ResultsDuring anesthesia and in the PACU, significantly more patients in the oximetry group had at least one respiratory event than did the control patients. This was the result of a 19-fold Increase in the incidence of diagnosed hypoxemia in the oximetry group than in the control group in both the OR and PACU (P < 0.00001). In the OR, cardiovascular events were observed In a similar number of patients in both groups, except myocardial ischemia (as denned by angina or ST-seg-ment depression), which was detected in 12 patients in the oximetry group and In 26 patients in the control group (P < 0.03). Several changes in PACU care were observed in association with the use of pulse oximetry. These Included higher flow rate of supplemental oxygen (P < 0.00001), Increased use of supplemental oxygen at discharge (P < 0.00001), and increased use of naloxone (P < 0.02). The rate of changes in patient care as a consequence of the oximetry monitoring Increased as the American Society of Anesthesiologists physical status worsened (P < 0.00001). One or more postoperative complications occurred in 10% of the patients in the oximetry group and in 9.4% in the control group (difference not significant). The two groups did not differ significantly in cardiovascular, respiratory, neurologic, or Infectious complications. The duration of hospital stay was a median of 5 days in both groups (difference not significant). An equal number of in-hospital deaths were registered in the two groups. Questionnaires, completed by the anesthesiologists at the five partlc

Procalcitonin increase in early identification of critically ill patients at high risk of mortality.

Objective:To investigate day-by-day changes in procalcitonin and maximum obtained levels as predictors of mortality in critically ill patients. Design:Prospective observational cohort study. Setting:Multidisciplinary intensive care unit at Rigshospitalet, Copenhagen University Hospital, a tertiary reference hospital in Denmark. Patients:Four hundred seventy-two patients with diverse comorbidity and age admitted to this intensive care unit. Interventions:Equal in all patient groups: antimicrobial treatment adjusted according to the procalcitonin level. Measurements and Main Results:Daily procalcitonin measurements were carried out during the study period as well as measurements of white blood cell count and C-reactive protein and registration of comorbidity. The primary end point was all-cause mortality in a 90-day follow-up period. Secondary end points were mortality during the stay in the intensive care unit and in a 30-day follow-up period. A total of 3,642 procalcitonin measurements were evaluated in 472 critically ill patients. We found that a high maximum procalcitonin level and a procalcitonin increase for 1 day were independent predictors of 90-day all-cause mortality in the multivariate Cox regression analysis model. C-reactive protein and leukocyte increases did not show these qualities. The adjusted hazard ratio for procalcitonin increase for 1 day was 1.8 (95% confidence interval 1.3–2.7). The relative risk for mortality in the intensive care unit for patients with an increasing procalcitonin was as follows: after 1 day increase, 1.8 (95% confidence interval 1.4–2.4); after 2 days increase, 2.2 (95% confidence interval 1.6–3.0); and after 3 days increase: 2.8 (95% confidence interval 2.0–3.8). Conclusions:A high maximum procalcitonin level and a procalcitonin increase for 1 day are early independent predictors of all-cause mortality in a 90-day follow-up period after intensive care unit admission. Mortality risk increases for every day that procalcitonin increases. Levels or increases of C-reactive protein and white blood cell count do not seem to predict mortality.

Randomized evaluation of pulse oximetry in 20,802 patients: I. Design, demography, pulse oximetry failure rate, and overall complication rate.

BackgroundAlthough pulse oximetry is currently In widespread use, there are few data documenting Improvement in patient outcome as a result of the use of oximetry. The authors describe the study design, patient demographic findings, data validation, pulse oximetry failure rate, and overall postoperative complication rates in the first large prospective randomized multicenter clinical trial on perloperative pulse oximetry monitoring. Methods;In five Danish hospitals, by random assignment, monitoring did or did not include pulse oximetry for patients 18 yr of age and older, whether scheduled for elective or emergency operations, or for regional or general anesthesia, except during cardiac and neurosurgical procedures. Operational definitions were established for perioperative events and postoperative complications. The data were collected preoperatively, during anesthesia, in the postanesthesia care unit, and until the day of discharge from the hospital or the seventh postoperative day. ResultsOf 20,802 patients, 10,312 were assigned to the oximetry group and 10,490, to the control group. In general, the demographic data, patient factors, and anesthetic agents used were distributed evenly. A slight intergroup difference was found in the distribution of age, duration of surgery, some types of surgery, and some types of anesthesia. The total failure rate of the oximetry was 2.5%, but it increased to 7.2% in patients with American Society of Anesthesiologists physical status 4 (P < 0.00001). In 14.9% of the patients, one or more events occurred in the operating room and 13.5% in the postanesthesia care unit. The overall postoperative complication rate was 9.7%. The total rates of cardiovascular and respiratory complications were 2.78% and 3.50%, respectively. Within the